Hepatocellular carcinoma (HCC) is a deadly cancer prevalent in Asia, often diagnosed too late for effective treatment.
Researchers are focusing on early diagnosis and treatment by studying tumor-associated antigens.
The study found that CK10 levels are significantly higher in HCC cell lines compared to normal liver cells, indicating its potential as a new biomarker and therapeutic target for HCC.